Rallybio (RLYB) Common Equity (2023 - 2025)
Historic Common Equity for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $63.0 million.
- Rallybio's Common Equity fell 1099.16% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year decrease of 1099.16%. This contributed to the annual value of $61.7 million for FY2024, which is 4193.66% down from last year.
- According to the latest figures from Q3 2025, Rallybio's Common Equity is $63.0 million, which was down 1099.16% from $46.0 million recorded in Q2 2025.
- In the past 5 years, Rallybio's Common Equity registered a high of $155.2 million during Q1 2023, and its lowest value of $46.0 million during Q2 2025.
- Its 3-year average for Common Equity is $89.9 million, with a median of $80.0 million in 2024.
- Per our database at Business Quant, Rallybio's Common Equity plummeted by 4269.51% in 2024 and then plummeted by 1099.16% in 2025.
- Quarter analysis of 3 years shows Rallybio's Common Equity stood at $106.2 million in 2023, then plummeted by 41.94% to $61.7 million in 2024, then grew by 2.24% to $63.0 million in 2025.
- Its Common Equity stands at $63.0 million for Q3 2025, versus $46.0 million for Q2 2025 and $54.1 million for Q1 2025.